Head aT1D Early Detection Strategy and Partnerships

About The Job

At Sanofi, we are driven by one purpose – we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible.

We never settle and now we are creating a new paradigm with a first-in-class therapy in Autoimmune Type 1 Diabetes (aT1D), which aims to delay the onset of Stage 3 aT1D. The onset of Stage 3 aT1D can have a major impact for patients and caregivers, including eventually needing insulin for the rest of their lives. What delayed onset means is more time for patients and caregivers to continue to live without the daily challenges of Stage 3 aT1D, including daily use of insulin and monitoring. It gives families and healthcare professionals more time to prepare care plans for a later diagnosis.

Sanofi recognizes that early detection of aT1D and risk factors for developing aT1D could improve health outcomes for T1D patients. But many are unaware they are at risk of developing T1D, which highlights the important public health benefits associated with screening – as certain patients who are screened may potentially be appropriate for therapy upon further testing and consultation with their HCP. Detecting aT1D early can prevent years of moderately elevated blood sugar levels and also potentially reduce the risk of going through Diabetic KetoAcidosis (“DKA”), which is a serious complication of diabetes that can lead to hospitalization and be life-threatening. Undiagnosed aT1D can be fatal – and early detection can save lives. It is therefore critical that people be proactively screened to help identify their risk for aT1D, before symptoms appear. This is where you come in.

We now present an exciting opportunity for you to go further faster. If you’re excited by the prospect of helping to expand appropriate patient access to autoantibody screening tests, then we want to hear from you as we have built a great team to facilitate increased aT1D screening for appropriate patients, allowing for early detection, education, and treatment.

This is a chance to bring your strategic experience, curiosity, problem-solving skills, exceptional people and cross functional leadership energy and expertise to a truly transformative and career-defining leadership role where you can help change countless lives. In return, you will have a rare opportunity in pharma – the chance to help disrupt and delay a debilitating and widespread disease.

This role is critical within the US aT1D team and a key strategic contributor and influencer; this role reports to the Head of the aT1D business in the US, and offers you executive level visibility, dynamic and fast paced challenges, ability to accelerate business transformation and healthcare for patients. You will also partner with key 3rd party screening infrastructure players on strategic opportunities.

Innovation, patient focus and disruptive thinking are all key threads of our Play To Win culture.

We are seeking a highly strategic, motivated, and visionary leader interested in shaping the early identification of people at risk of developing autoimmune Type 1 Diabetes (aT1D). This individual will be responsible for leading the development and coordinating the implementation of the US strategy for accelerated aT1D screening across all stakeholders.

They will be expected to collaborate and communicate effectively in a matrix organization with significant interactions with Brand Marketing, Sales, Medical, Market Access, Market Research, Finance, Analytics, Business Operations and Senior Leadership. This role will report to the Head of the aT1D Business in the US and sit on the leadership team.

We are an innovative global healthcare company with a focus on immunology that extends to innovation in diabetes and transplant medicine. Across different countries, our talented teams are determined to deliver a best-in-class customer experience using the best of digital, artificial intelligence and personal know-how. With a focus on immunology that extends to innovation in diabetes and transplant medicines, we pursue progress to make a real impact on millions of patients around the world.

Main Responsibilities

• Responsible for the successful development of the US accelerated aT1D Screening Strategy, resulting in the advancement of an ecosystem to facilitate the integration of aT1D screening in routine health care.
• Partner with the Head of Tzield Marketing and Head of Customer Engagement team (incl. Sales) and other field based teams to align on business objectives and priorities, and ensure strong execution such as driving education, awareness and adoption of aT1D screening with HCPs, patients, patient organizations and professional associations.
• Ensure consistency in messaging across external stakeholders, in strong partnership with the Tzield marketing team.
• In partnership with the Tzield marketing, medical and advocacy teams (and other internal stakeholders), lead national/regional/local screening initiatives/programs, as well as the development and dissemination of screening/monitoring guidelines & consensus statements.
• Manage and report on screening performance with emphasis on market analytics and measuring key performance indicators.
• Identify key opportunities and partnerships to improve aT1D screening and monitoring by identifying new diagnostic channels and methodologies while always ensuring appropriate compliance assessment and validation.
• Engage within highly functional matrix teams with effective communication, partnership and collaboration.

Experience

About You

Bachelor's degree in life sciences, marketing or business required; advanced degree preferred.

At least 10+ years of US bio-pharma leadership experience across commercial or other patient- or HCP-facing organizations with proven track record of success.

Experience building strong partnerships and alliances, preferably with screening/testing infrastructure players.

Previous experience leading P&L ownership decisions, defining product strategy and operating budget.

Prior experience with aT1D or rare diseases where screening is desired.

Specialty care experience is a plus.

Commercial experience in Pediatric and Primary Care markets is an asset.

Technical Skills

Strong background in national health initiatives, or launching products requiring monitoring/screening.

Experience in building partnerships with screening infrastructure players and in developing data-driven solutions, including AI to monitor and identify people at risk.

Experience in product launch & launch excellence in specialty care or rare diseases.

Professional Skills/behaviors

Excellent organizational, interpersonal, collaboration and communication skills. Demonstrated ability to communicate effectively with senior leaders.

Performance orientation and demonstrated ability to deliver along accelerated timelines.

Ability to lead in an ambiguous environment across different functions.

Strong strategic thinking skills and prioritizing capacity are required.

Analytic capabilities with the ability to understand, simplify and communicate effectively with others.

Collaboration, conceptual and innovation skills.

Demonstrated ability to coach and motivate teams.

Readiness to travel (up to 35% of time).

Languages

Strong communication and presentation skills in English required

Why Choose Us?

Bring the miracles of science to life alongside a supportive, future-focused team.

Discover endless opportunities to grow your talent and drive your career, whether it’s through a promotion or lateral move, at home or internationally.

Enjoy a thoughtful, well-crafted rewards package that recognizes your contribution and amplifies your impact.

Take good care of yourself and your family, with a wide range of health and wellbeing benefits including high-quality healthcare, prevention and wellness programs and at least 14 weeks’ gender-neutral parental leave.

BRIDGEWATER, NJ ONLY – Office Location Update

Sanofi's Bridgewater, NJ office is scheduled to relocate to Morristown, NJ on or around March 24, 2025 and this role will then be based in Morristown, NJ.

Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.

#GD-SG

#vhd